Literature DB >> 19130024

Immune-mediated CNS damage.

Katrin Kierdorf1, Yiner Wang, Harald Neumann.   

Abstract

Multiple sclerosis (MS) is a demyelinating autoimmune disease. However, the persisting neurological deficits in MS patients result from acute axonal injury and chronic neurodegeneration, which are both triggered by the autoreactive immune response. Innate immunity, mainly mediated by activated microglial cells and invading macrophages, appears to contribute to chronic neurodegeneration. Activated microglia produce several reactive oxygen species and proinflammatory cytokines which affect neuronal function, integrity and survival. Adaptive immunity, particularly in cytotoxic CD8+ T cells, participates in acute demyelination and axonal injury by directly attacking oligodendrocytes and possibly neurons as well. Understanding the mechanisms of immune-mediated neuronal damage might help to design novel therapy strategies for MS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19130024     DOI: 10.1007/400_2008_15

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  14 in total

1.  Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis.

Authors:  Francesco Mori; Carolina G Nicoletti; Silvia Rossi; Caterina Motta; Hajime Kusayanagi; Alessandra Bergami; Valeria Studer; Fabio Buttari; Francesca Barbieri; Sagit Weiss; Robert Nisticò; Gianvito Martino; Roberto Furlan; Diego Centonze
Journal:  Neuromolecular Med       Date:  2014-03-27       Impact factor: 3.843

2.  Reactive retinal microglia, neuronal survival, and the formation of retinal folds and detachments.

Authors:  Andy J Fischer; Christopher Zelinka; Nima Milani-Nejad
Journal:  Glia       Date:  2014-09-18       Impact factor: 7.452

3.  Control of macrophage autophagy by miR-384-5p in the development of diabetic encephalopathy.

Authors:  Beiyun Wang; Jing Huang; Jingbo Li; Yuan Zhong
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

4.  A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats.

Authors:  Tarek K Motawi; Hebatallah A Darwish; Manal A Hamed; Nagy S El-Rigal; Asmaa F Aboul Naser
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

Review 5.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

6.  Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.

Authors:  Irena Dujmovic
Journal:  Mult Scler Int       Date:  2011-05-02

Review 7.  Oxidized cholesterol as the driving force behind the development of Alzheimer's disease.

Authors:  Paola Gamba; Gabriella Testa; Simona Gargiulo; Erica Staurenghi; Giuseppe Poli; Gabriella Leonarduzzi
Journal:  Front Aging Neurosci       Date:  2015-06-19       Impact factor: 5.750

Review 8.  Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.

Authors:  Dominika Justyna Ksiazek-Winiarek; Piotr Szpakowski; Andrzej Glabinski
Journal:  Neural Plast       Date:  2015-07-02       Impact factor: 3.599

Review 9.  Microglial cell dysregulation in brain aging and neurodegeneration.

Authors:  Rommy von Bernhardi; Laura Eugenín-von Bernhardi; Jaime Eugenín
Journal:  Front Aging Neurosci       Date:  2015-07-20       Impact factor: 5.750

10.  Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.

Authors:  Manjit Braitch; Kiyokazu Kawabe; Mukanthu Nyirenda; Lucie Jean Gilles; R Adrian Robins; Bruno Gran; Sean Murphy; Louise Showe; Cris S Constantinescu
Journal:  Neuroimmunomodulation       Date:  2009-11-17       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.